Development of a Novel Tool To Demystify Drug Distribution at Tissue-Blood Barriers
- PMID: 36951632
- DOI: 10.1002/cbic.202200804
Development of a Novel Tool To Demystify Drug Distribution at Tissue-Blood Barriers
Abstract
Tissue endothelial cells express ABC-transporter enzymes that change the concentration of small molecules within different tissue compartments. These "blood-tissue barriers" have been shown to directly affect the efficacy and toxicity of anticancer, antimicrobial, psychiatric, and anti-epileptic drugs. Currently this phenomenon is best studied for the blood-brain barrier, but remains enigmatic for most other tissues. In addition, canonical pharmacokinetic theory specifically assumes an equal concentration of free drug within all tissue compartments. Inspired by Lipinski's "rule of 5," we here clarify current knowledge on drug-tissue distribution by: 1) curating the in-vivo literature on 73 drugs across 23 tissues and 2) developing two graphical web-based applications to visually describe and interpret data. These curated in-vivo dataset and visualization tools enabled us to achieve new insights into the logic of the barrier-tissue organization and showed remarkable correspondence to whole-body imaging of radiolabeled molecules.
Keywords: bioinformatics; biological activity; biotransformation; blood-tissue barrier; drug delivery; volume of distribution.
© 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH.
Similar articles
-
Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.BMC Neurosci. 2013 Jun 18;14:59. doi: 10.1186/1471-2202-14-59. BMC Neurosci. 2013. PMID: 23773766 Free PMC article.
-
Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells.Curr Pharm Des. 2017;23(28):4198-4205. doi: 10.2174/1381612823666170727144450. Curr Pharm Des. 2017. PMID: 28748755 Review.
-
BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):37-54. doi: 10.1007/s10928-011-9229-x. Epub 2011 Dec 10. J Pharmacokinet Pharmacodyn. 2012. PMID: 22161221 Free PMC article.
-
Quantitative prediction of pharmacokinetic properties of drugs in humans: Recent advance in in vitro models to predict the impact of efflux transporters in the small intestine and blood-brain barrier.J Pharmacol Sci. 2022 Jan;148(1):142-151. doi: 10.1016/j.jphs.2021.10.010. Epub 2021 Nov 2. J Pharmacol Sci. 2022. PMID: 34924119 Review.
-
In Vitro and Ex Vivo Model Systems to Measure ABC Transporter Activity at the Blood-Brain Barrier.Curr Pharm Des. 2016;22(38):5768-5773. doi: 10.2174/1381612822666160810145536. Curr Pharm Des. 2016. PMID: 27514708 Review.
Cited by
-
The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery.Pharmaceuticals (Basel). 2025 Mar 18;18(3):424. doi: 10.3390/ph18030424. Pharmaceuticals (Basel). 2025. PMID: 40143200 Free PMC article. Review.
References
-
- None
-
- B. K. Forscher, Science 1963, 142, 339;
-
- P. Nurse, Nature 2021, 597, 305-305.
-
- None
-
- J. S. Boehm, M. J. Garnett, D. J. Adams, H. E. Francies, T. R. Golub, W. C. Hahn, F. Iorio, J. M. McFarland, L. Parts, F. Vazquez, Nature 2021, 589, 514-516;
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources